KR100364466B1 - 주사용메스나용액,이의제조방법및이를함유하는약제 - Google Patents

주사용메스나용액,이의제조방법및이를함유하는약제 Download PDF

Info

Publication number
KR100364466B1
KR100364466B1 KR1019930020576A KR930020576A KR100364466B1 KR 100364466 B1 KR100364466 B1 KR 100364466B1 KR 1019930020576 A KR1019930020576 A KR 1019930020576A KR 930020576 A KR930020576 A KR 930020576A KR 100364466 B1 KR100364466 B1 KR 100364466B1
Authority
KR
South Korea
Prior art keywords
solution
injection
injectable
scalpel
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019930020576A
Other languages
English (en)
Korean (ko)
Other versions
KR940008678A (ko
Inventor
위르겐엥겔
엘리자베트볼프-호이스
볼프강데거
지안카를로카뮤글리아
디터자우어비어
Original Assignee
아스타 메디카 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스타 메디카 악티엔게젤샤프트 filed Critical 아스타 메디카 악티엔게젤샤프트
Publication of KR940008678A publication Critical patent/KR940008678A/ko
Application granted granted Critical
Publication of KR100364466B1 publication Critical patent/KR100364466B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105Persulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
KR1019930020576A 1992-10-08 1993-10-06 주사용메스나용액,이의제조방법및이를함유하는약제 Expired - Lifetime KR100364466B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen
DEP4233842.5 1992-10-08

Publications (2)

Publication Number Publication Date
KR940008678A KR940008678A (ko) 1994-05-16
KR100364466B1 true KR100364466B1 (ko) 2003-01-29

Family

ID=6469925

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930020576A Expired - Lifetime KR100364466B1 (ko) 1992-10-08 1993-10-06 주사용메스나용액,이의제조방법및이를함유하는약제

Country Status (28)

Country Link
US (2) US5728738A (https=)
EP (1) EP0591710B1 (https=)
JP (1) JP3636372B2 (https=)
KR (1) KR100364466B1 (https=)
CN (1) CN1071114C (https=)
AT (1) ATE139693T1 (https=)
AU (1) AU667129B2 (https=)
BR (1) BR9304151A (https=)
CA (1) CA2107961C (https=)
CZ (1) CZ284584B6 (https=)
DE (2) DE4233842A1 (https=)
DK (1) DK0591710T3 (https=)
EG (1) EG20308A (https=)
ES (1) ES2089661T3 (https=)
FI (1) FI111804B (https=)
GR (1) GR3020669T3 (https=)
HK (1) HK7397A (https=)
HR (1) HRP931267B1 (https=)
HU (1) HU217123B (https=)
IL (1) IL107187A (https=)
NO (1) NO303712B1 (https=)
NZ (1) NZ248873A (https=)
RU (1) RU2105550C1 (https=)
SI (1) SI9300525A (https=)
SK (1) SK279609B6 (https=)
TW (1) TW279131B (https=)
UA (1) UA26134C2 (https=)
ZA (1) ZA937458B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6031006A (en) * 1999-10-21 2000-02-29 Bionumerik Pharmaceuticals, Inc. Method of treating diabetic nephropathy
TW201036529A (en) 2009-03-25 2010-10-01 Askey Computer Corp A liquid crystal anti-freeze method and a liquid crystal module using the liquid crystal anti-freeze method
UA74097U (ru) * 2012-07-24 2012-10-10 Николай Иванович Гуменюк Способ изготовления средства для лечения туберкулеза
ES2762880T3 (es) 2013-05-07 2020-05-26 Auxin Surgery Sa Dispositivo para disección asistida químicamente
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique
EP3429555B1 (en) * 2016-03-14 2020-04-29 AuXin Surgery SA Mesna formulation and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770A1 (de) * 1981-03-25 1982-10-07 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Verwendung von dimercaptopropansulfonsaeure und dimercaptobernsteinsaeure zur herstellung von pharmazeutischen mitteln
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
FI934410L (fi) 1994-04-09
DK0591710T3 (da) 1996-09-30
CN1089137A (zh) 1994-07-13
JP3636372B2 (ja) 2005-04-06
HU9302837D0 (en) 1993-12-28
ATE139693T1 (de) 1996-07-15
KR940008678A (ko) 1994-05-16
EG20308A (en) 1998-10-31
DE59303067D1 (de) 1996-08-01
IL107187A0 (en) 1994-01-25
SK279609B6 (sk) 1999-01-11
NZ248873A (en) 1995-10-26
NO303712B1 (no) 1998-08-24
CZ209793A3 (en) 1994-04-13
HK7397A (en) 1997-01-24
ES2089661T3 (es) 1996-10-01
HUT65096A (en) 1994-04-28
JPH06263629A (ja) 1994-09-20
SI9300525A (en) 1994-06-30
CA2107961A1 (en) 1994-04-09
US5696172A (en) 1997-12-09
UA26134C2 (uk) 1999-06-07
NO933590D0 (no) 1993-10-07
CZ284584B6 (cs) 1999-01-13
BR9304151A (pt) 1994-06-07
IL107187A (en) 1999-03-12
ZA937458B (en) 1994-04-26
CN1071114C (zh) 2001-09-19
HRP931267A2 (en) 1994-12-31
HRP931267B1 (en) 1997-08-31
DE4233842A1 (de) 1994-04-14
US5728738A (en) 1998-03-17
AU667129B2 (en) 1996-03-07
EP0591710B1 (de) 1996-06-26
AU4888393A (en) 1994-04-21
HU217123B (hu) 1999-11-29
RU2105550C1 (ru) 1998-02-27
SK107993A3 (en) 1994-05-11
CA2107961C (en) 2003-03-25
FI934410A0 (fi) 1993-10-07
GR3020669T3 (en) 1996-10-31
TW279131B (https=) 1996-06-21
FI111804B (fi) 2003-09-30
EP0591710A1 (de) 1994-04-13
NO933590L (no) 1994-04-11

Similar Documents

Publication Publication Date Title
AU2002216042B2 (en) Freeze-dried pantoprazole preparation and pantoprazole injection
KR100735788B1 (ko) 일반 염을 함유하는 목시플록사신 제형
EP2193795B1 (en) Latanoprost-containing aqueous pharmaceutical composition
EA008308B1 (ru) Жидкие стабилизированные белковые составы в фармацевтических контейнерах с покрытием
KR100364466B1 (ko) 주사용메스나용액,이의제조방법및이를함유하는약제
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
US11324692B2 (en) Method to prepare pharmaceutical compositions of suggamadex
CA2090911C (en) Aqueous pharmaceutical formulations of sodium cromoglycate
JP3744857B2 (ja) アルファ−2,4−ジスルホフェニル−N−tert−ブチルニトロンの新規な処方物
CA1314231C (en) Ifosphamide lyophilisate and process for its preparation
US5834520A (en) Container for injectable mesna solutions
HUP0202246A2 (en) Multi-dose erythropoietin formulations
MXPA03002770A (es) Infusion de ciprofloxacina con un contenido de acido reducido y estable al almacenamiento.
JP3271650B2 (ja) 重炭酸イオン含有無菌性配合液剤又は製剤及びその製造方法
WO2022130033A1 (en) An aqueous sterile solution of atropine for ophthalmic use
US3681495A (en) Freeze dried echothiophate iodide compositions
SI9300029A (en) Lecithin-containing solutions with levemopamil
WO2022130337A1 (en) An aqueous sterile solution of atropine for ophthalmic use
EP3932391A1 (en) Method to prepare pharmaceutical compositions
GB2262448A (en) Aqueous formulations of sodium cromoglycate
JPH04103531A (ja) ニトログリセリン水性注射剤

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19931006

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980710

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19931006

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20000520

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20010316

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20000520

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20010414

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20010316

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20020730

Appeal identifier: 2001101001044

Request date: 20010414

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20010514

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20010414

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20000920

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 19980710

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010414

Effective date: 20020730

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20020731

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20010414

Decision date: 20020730

Appeal identifier: 2001101001044

PS0901 Examination by remand of revocation
S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
PS0701 Decision of registration after remand of revocation

Patent event date: 20020902

Patent event code: PS07012S01D

Comment text: Decision to Grant Registration

Patent event date: 20020807

Patent event code: PS07011S01I

Comment text: Notice of Trial Decision (Remand of Revocation)

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20021129

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20021202

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20051125

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20061121

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20071126

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20081121

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20091120

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20101111

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20111109

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20121107

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20121107

Start annual number: 11

End annual number: 11

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20140406

Termination category: Expiration of duration